Altos Labs, founded by Bryan Johnson, is a biotechnology company focused on developing advanced technologies to extend human healthspan. Healthspan refers to the period during which an individual remains free from significant age-related diseases.
The primary problem addressed by Altos Labs is the reduction in quality of life associated with aging, particularly through the prevention or mitigation of age-related diseases such as cardiovascular disease, neurodegenerative disorders, and cancer.
The company employs a multidisciplinary approach involving stem cell research, genetics, and molecular biology to identify and target biological processes that contribute to aging and age-related diseases. Through these efforts, Altos Labs aims to develop therapies that can delay the onset of these conditions, thereby extending healthspan.
Altos Labs operates a research facility focused on developing biotechnological solutions. The manufacturing process involves laboratory-scale experiments to identify potential therapeutic targets and validate their efficacy before scaling up for clinical trials and eventual commercialization.
The build process at Altos Labs includes extensive preclinical testing, including in vitro and in vivo studies, to ensure the safety and effectiveness of proposed therapies. This is followed by rigorous regulatory approval processes before any treatments can be made available to patients.
Curated names only — none are invented. Use the link to find more.
Cost drivers only — no verified dollar figures are shown. Check live sources for prices.
Illustrative — search real, dated examples rather than trusting a generated story.
Live searches — we don't list papers we can't verify.
Live patent searches — filings are never listed from memory.
Verify against primary sources only.
Source: curated technology intelligence stream with tracked references.